CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion | +17,734 | 68,723 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion | +3,193 | 1,361,921 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion | +60,135 | 60,135 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion | +21,527 | 81,662 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion | +5,286 | 86,948 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Option exercise · Warrant to Purchase Series A Preferred Stock | −19,976 | 0 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Option exercise · Series A Preferred Stock | +19,976 | $1.25 | $25K | 60,135 |
| 2014-11-12 | Lanfear Dennis M See Remarks | Option exercise · Warrant to Purchase Series B Preferred Stock | −3,225 | 0 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Option exercise · Series B Preferred Stock | +3,225 | $0.02 | $54 | 17,734 |
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion · Series B Preferred Stock | −17,734 | 0 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion · Series B Preferred Stock | −3,193 | 0 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion · Series A Preferred Stock | −60,135 | 0 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion · Series B Preferred Stock | −21,527 | 0 | ||
| 2014-11-12 | Lanfear Dennis M See Remarks | Conversion · Series C Preferred Stock | −5,286 | 0 | ||
| 2014-11-12 | Troendle August J. Director | Conversion | +319,935 | 319,935 | ||
| 2014-11-12 | Troendle August J. Director | Conversion | +1,556,055 | 1,875,990 | ||
| 2014-11-12 | Troendle August J. Director | Conversion | +266,502 | 2,142,492 | ||
| 2014-11-12 | Troendle August J. Director | Conversion | +358,428 | 358,428 | ||
| 2014-11-12 | Troendle August J. Director | Option exercise · Warrant to Purchase Series B Preferred Stock | −107,528 | 0 | ||
| 2014-11-12 | Troendle August J. Director | Option exercise · Series B Preferred Stock | +107,528 | $0.02 | $2K | 1,556,055 |
Page 37 of 39 · 768 trades